Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: a randomized feasibility and safety study.
Lipsic E, van der Meer P, Voors AA, Westenbrink BD, van den Heuvel AF, de Boer HC, van Zonneveld AJ, Schoemaker RG, van Gilst WH, Zijlstra F, van Veldhuisen DJ. Lipsic E, et al. Cardiovasc Drugs Ther. 2006 Apr;20(2):135-41. doi: 10.1007/s10557-006-7680-5. Cardiovasc Drugs Ther. 2006. PMID: 16761193 Clinical Trial.
Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.
Westenbrink BD, Lipsic E, van der Meer P, van der Harst P, Oeseburg H, Du Marchie Sarvaas GJ, Koster J, Voors AA, van Veldhuisen DJ, van Gilst WH, Schoemaker RG. Westenbrink BD, et al. Among authors: lipsic e. Eur Heart J. 2007 Aug;28(16):2018-27. doi: 10.1093/eurheartj/ehm177. Epub 2007 Jun 17. Eur Heart J. 2007. PMID: 17576662
Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the glycometabolic intervention as adjunct to primary percutaneous intervention in ST elevation myocardial infarction (GIPS)-III trial.
Lexis CP, van der Horst IC, Lipsic E, van der Harst P, van der Horst-Schrivers AN, Wolffenbuttel BH, de Boer RA, van Rossum AC, van Veldhuisen DJ, de Smet BJ; GIPS-III Investigators. Lexis CP, et al. Among authors: lipsic e. Cardiovasc Drugs Ther. 2012 Oct;26(5):417-26. doi: 10.1007/s10557-012-6413-1. Cardiovasc Drugs Ther. 2012. PMID: 22968678 Free PMC article. Clinical Trial.
The feasibility of optical coherence tomography guided thrombus aspiration in patients with non-ST-elevation myocardial infarction after initial conservative therapy--a pilot study.
Wieringa WG, Lexis CP, Diercks GF, Lipsic E, Tan ES, Schurer RA, van der Werf HW, van den Heuvel AF, Suurmeijer AJ, Zijlstra F, de Smet BJ, Pundziute G. Wieringa WG, et al. Among authors: lipsic e. Int J Cardiol. 2013 Oct 12;168(5):4981-2. doi: 10.1016/j.ijcard.2013.07.133. Epub 2013 Aug 3. Int J Cardiol. 2013. PMID: 23916781 No abstract available.
Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial.
Lexis CP, van der Horst IC, Lipsic E, Wieringa WG, de Boer RA, van den Heuvel AF, van der Werf HW, Schurer RA, Pundziute G, Tan ES, Nieuwland W, Willemsen HM, Dorhout B, Molmans BH, van der Horst-Schrivers AN, Wolffenbuttel BH, ter Horst GJ, van Rossum AC, Tijssen JG, Hillege HL, de Smet BJ, van der Harst P, van Veldhuisen DJ; GIPS-III Investigators. Lexis CP, et al. Among authors: lipsic e. JAMA. 2014 Apr 16;311(15):1526-35. doi: 10.1001/jama.2014.3315. JAMA. 2014. PMID: 24687169 Clinical Trial.
112 results